Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Ruta Sawant

Showing results (1-10 of 11) with videos related to

Pageof 2
Sort By:
Pharmacy Practice|July 20, 2018
Communicating risk of medication side-effects: role of communication format on risk perceptionRuta Sawant, Sujit Sansgiry
Advances in Therapy|April 10, 2021
Healthcare Costs of Not Achieving Remission in Patients with Rheumatoid Arthritis in the United States: A Retrospective Cohort StudyMartin Bergman, Lili Zhou, Pankaj Patel, et al.
Modern Rheumatology|February 10, 2022
Number needed to treat and cost per responder of Janus kinase inhibitors approved for the treatment of moderate-to-severe rheumatoid arthritis in JapanTatsuya Atsumi, Eri Asakura, Michio Doi, et al.
Health and Quality of Life Outcomes|April 16, 2024
Health state utility estimates for value assessments of novel treatments in Huntington's disease: a systematic literature reviewRuta Sawant, Kyle Paret, Jennifer Petrillo, et al.
Rheumatology and Therapy|November 27, 2020
A Matching-Adjusted Indirect Comparison of Upadacitinib Versus Tofacitinib in Adults with Moderate-to-Severe Rheumatoid ArthritisChristopher J Edwards, Ruta Sawant, Vishvas Garg, et al.
Advances in Therapy|November 17, 2021
Value of Remission in Patients with Rheumatoid Arthritis: A Targeted ReviewAndrew J Ostor, Ruta Sawant, Cynthia Z Qi, et al.
Journal of Huntington'S Disease|August 30, 2024
Rasch Measurement Theory (RMT) Analyses of the Huntington's Disease Everyday Functioning (Hi-DEF) to Evaluate Item Fit and PerformanceJennifer Petrillo, Ruta Sawant, Emma Elliott, et al.
Currents in Pharmacy Teaching & Learning|April 19, 2024
The role of implementing instructional design principles on learner experience with training in current good manufacturing practices (cGMP)Russell D Wilson, Sujit S Sansgiry, Ruta Sawant, et al.
Advances in Therapy|April 17, 2020
Comparative Efficacy of JAK Inhibitors for Moderate-To-Severe Rheumatoid Arthritis: A Network Meta-AnalysisJanet Pope, Ruta Sawant, Namita Tundia, et al.
Journal of Huntington'S Disease|July 22, 2025
Reliability and validity of the Huntington's Disease Everyday Functioning (Hi-DEF): A patient-reported measure of cognitive capacity on daily functioning in Huntington's diseaseJennifer Petrillo, Ruta Sawant, Rebecca Rogers, et al.
Pageof 2

Showing results (1-10 of 11) with videos related to

Sort By:
Pageof 2
Pharmacy Practice|July 20, 2018
Communicating risk of medication side-effects: role of communication format on risk perceptionRuta Sawant, Sujit Sansgiry
Advances in Therapy|April 10, 2021
Healthcare Costs of Not Achieving Remission in Patients with Rheumatoid Arthritis in the United States: A Retrospective Cohort StudyMartin Bergman, Lili Zhou, Pankaj Patel, et al.
Modern Rheumatology|February 10, 2022
Number needed to treat and cost per responder of Janus kinase inhibitors approved for the treatment of moderate-to-severe rheumatoid arthritis in JapanTatsuya Atsumi, Eri Asakura, Michio Doi, et al.
Health and Quality of Life Outcomes|April 16, 2024
Health state utility estimates for value assessments of novel treatments in Huntington's disease: a systematic literature reviewRuta Sawant, Kyle Paret, Jennifer Petrillo, et al.
Rheumatology and Therapy|November 27, 2020
A Matching-Adjusted Indirect Comparison of Upadacitinib Versus Tofacitinib in Adults with Moderate-to-Severe Rheumatoid ArthritisChristopher J Edwards, Ruta Sawant, Vishvas Garg, et al.
Advances in Therapy|November 17, 2021
Value of Remission in Patients with Rheumatoid Arthritis: A Targeted ReviewAndrew J Ostor, Ruta Sawant, Cynthia Z Qi, et al.
Journal of Huntington'S Disease|August 30, 2024
Rasch Measurement Theory (RMT) Analyses of the Huntington's Disease Everyday Functioning (Hi-DEF) to Evaluate Item Fit and PerformanceJennifer Petrillo, Ruta Sawant, Emma Elliott, et al.
Currents in Pharmacy Teaching & Learning|April 19, 2024
The role of implementing instructional design principles on learner experience with training in current good manufacturing practices (cGMP)Russell D Wilson, Sujit S Sansgiry, Ruta Sawant, et al.
Advances in Therapy|April 17, 2020
Comparative Efficacy of JAK Inhibitors for Moderate-To-Severe Rheumatoid Arthritis: A Network Meta-AnalysisJanet Pope, Ruta Sawant, Namita Tundia, et al.
Journal of Huntington'S Disease|July 22, 2025
Reliability and validity of the Huntington's Disease Everyday Functioning (Hi-DEF): A patient-reported measure of cognitive capacity on daily functioning in Huntington's diseaseJennifer Petrillo, Ruta Sawant, Rebecca Rogers, et al.
Pageof 2